Anti-complement factor H (CFH) antibodies and a novel CFH gene mutation in an atypical hemolytic uremic syndrome patient with complement activation of the classical pathway-Reference-Cited by-同舟云学术

Anti-complement factor H (CFH) antibodies and a novel CFH gene mutation in an atypical hemolytic uremic syndrome patient with complement activation of the classical pathway

Published:2021-03-30 Issue:4 Volume:44 Page:274-277
ISSN:2578-5826
Container-title:Immunological Medicine
language:en
Short-container-title:Immunological Medicine

Author:

Minato Sonoko¹²^ORCID,Iijima Hiroyuki¹,Nakao Hiro¹,Nishi Kentaro³,Hidaka Yoshihiko⁴,Inoue Norimitsu⁴,Kubota Mitsuru¹,Ishiguro Akira²⁵^ORCID

Affiliation:

1. Department of General Pediatrics & Interdisciplinary Medicine, National Center for Child Health and Development (NCCHD), Tokyo, Japan

2. Center for Postgraduate Education and Training, NCCHD, Tokyo, Japan

3. Division of Nephrology and Rheumatology, NCCHD, Tokyo, Japan

4. Department of Molecular Genetics, Wakayama Medical University, Wakayama, Japan

5. Division of Hematology, NCCHD, Tokyo, Japan

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/25785826.2021.1905303

Reference10 articles.

Epidemiology of Atypical Hemolytic Uremic Syndrome: A Systematic Literature Review

2. Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome

3. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

4. Complement Factor H–Related Protein 1 Deficiency and Factor H Antibodies in Pediatric Patients with Atypical Hemolytic Uremic Syndrome

5. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS